Objective: The aim was to examine the adrenergic modulation of endogenous acetylcholine (ACh) release from vagal nerve terminals in the in vivo heart. Methods: Using dialysis technique in anesthetized cats, we investigated the influence of exogenous noradrenaline on dialysate ACh response. Dialysis probes were implanted in the left ventricular myocardium and perfused with Krebs-Henseleit buffer of Ca influx through the N-type Ca channels could play a predominant role in the decrease in ACh release.
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in cardiac cells [1, 2] . In the isolated rabbit heart [3] and in vivo rat heart [4] , a-adrenergic receptor agonists inhibited the cardiac chronotropic responses to vagal nerve stimulation, but did 1. Introduction not inhibit the responses to muscarinic agonists. These studies have proposed the prejunctional adrenergic moduSympathetic-parasympathetic interactions take place not lation of cardiac vagal functions in the periphery. On the only within the central nervous system but also in the other hand, in the guinea pig atria [5] and in vivo dog heart periphery. Peripheral sympathetic-parasympathetic inter- [6] , noradrenaline or a-adrenergic agonists failed to inhibit actions on cardiac regulation have been well studied.
the cardiac chronotropic responses to field or vagal nerve Several types of mechanisms responsible for these stimulations. These studies have suggested that there is no peripheral interactions have been proposed including preprejunctional adrenergic modulation of cardiac vagal funcjunctional vagal inhibition of noradrenaline release from tions. Thus, the evidence for prejunctional adrenergic modulation of cardiac vagal functions is controversial. There have been, however, only a few studies directly investigating adrenergic modulation of acetylcholine (ACh) handmade long transverse dialysis probe. One end of release in the mammalian heart [7, 8] . Moreover, in anespolyethylene tube (50 cm length, 0.5 mm OD, and 0.2 mm thetized rat, two sites along the cardiac vagal pathway have ID) was dilated by a 27-gauge needle (0.40 mm OD). Each been suggested to be responsible for prejunctional adrenend of the dialysis fiber (18 mm length, 0.31 mm OD, and ergic modulation of cardiac vagal functions: presynaptic 0.20 mm ID; PAN-1200 50 000-molecular weight cutoff, terminals and ganglion cells [9] . Therefore, it is important Asahi Chemical, Japan) was inserted into a polyethylene to clearly define the prejunctional adrenergic modulatory tube and glued. To be connected with dialysis probe, site in the intracardiac vagal pathway: preganglionic guiding needle consisted of two parts: a sharp side (30 mm nerves, ganglion cells, or postganglionic nerve terminals. length, 0.51 mm OD) and a blunt side (5 mm length, 0.25 Previously, we monitored endogenous ACh release from mm OD). cardiac vagal nerve terminals in the in vivo heart by Dialysis probes were perfused with Krebs-Henseleit dialysis technique [10] . We considered it possible to solution at a speed of 3 ml / min using a microinjection examine the adrenergic modulation of ACh release in the pump (Carnegie Medicin CMA / 100). Krebs-Henseleit in vivo heart by dialysis technique. In the present study, buffer consisted of (in mM) 118.0 NaCl, 25.0 NaHCO , 3 we focused on presynaptic adrenergic modulation of ACh 4.7 KCl, 2. from cardiac vagal nerve terminals. ACh assay was mg / kg i.v.). The animals were intubated and ventilated conducted using high-performance liquid chromatography with a constant-volume respirator using room air mixed with electrochemical detection as previously described with oxygen. Heart rate, arterial pressure, and electro- [10] . The dialysate sample from the myocardium was cardiogram were monitored and recorded continuously.
directly injected into the liquid chromatograph. The ACh Anesthetic was supplemented as necessary. With the concentration was determined by measuring the area under animal in the lateral position, the fifth or sixth rib on the the chromatogram. left side was partially removed to expose the heart. A small
In our previous study of myocardial interstitial noradincision was made in the pericardium, and with a fine renaline monitoring, the control dialysate noradrenaline guiding needle, two dialysis probes were implanted in the concentration decreased over the first 120 min, subsequentleft ventricular anterolateral wall of the beating heart along ly reaching an almost steady level [11] . To avoid the the long axis. The cervical vagosympathetic trunks were possibility that this alteration in noradrenaline concentransected, and shielded bipolar palladium electrodes were tration may affect ACh release, we discarded the first 120 applied to the distal ends of both nerves, which were then min of dialysate and commenced the protocol 120 min stimulated by a digital stimulator (Nihon Kohden SENafter probe implantation. 7203) with a rectangular pulse (10 V and 1 ms in duration) during collection of one dialysate sample. A heating pad and lamp were used to keep epicardial and core tempera-2.3. Experimental protocols ( Fig. 1 ) ture within a range of 37-398C. Heparin sodium (200 U / kg) was administered intravenously and then 100 U / kg
In all protocols, we locally administered pharmacowas given every 2 h to prevent blood coagulation.
logical agents by perfusing Krebs-Henseleit solution containing those through the dialysis probe. To eliminate 2.2. In vivo dialysis technique the influence of chronotropic changes on dialysate ACh concentration, we maintained heart rate at the level before Materials suitable for cardiac dialysis probe have been transection by electrical ventricular pacing during vagal described in detail elsewhere [10] . Briefly, we designed a nerve stimulation. 21 We investigated the influence of noradrenaline on [13, 14] . To examine the involvement of N-type Ca dialysate ACh response in the presence of the a-adrenergic channel gating in adrenergic inhibition, we investigated the antagonist phentolamine in six cats. noradrenaline on dialysate ACh response was 4465%. At the end of the experiment the cats were killed with pentobarbital sodium and the implant sites were examined.
3.2. Protocol 2: effect of phentolamine on The dialysis probes had been implanted in the middle layer noradrenaline-induced inhibition (Fig. 2 ) of the myocardium of the left ventricular anterolateral wall; no bleeding or necrosis was found macroscopically.
Control dialysate ACh response to vagal nerve stimulation (10 Hz) was 9.862.7 nM in the presence of phentolamine. This value was almost the same as that in the 2. 4 (Fig. 3) 
Results
Nifedipine did not attenuate the dialysate ACh response In all protocols, local administration of pharmacological to vagal nerve stimulation (10 Hz) (from 9.461.8 to agents did not alter heart rate and mean arterial blood 9.361.2, n54). v-Conotoxin GVIA significantly atpressure. Heart rate was maintained at 150-200 beats / min tenuated the dialysate ACh response from 9.661.2 to during vagal nerve stimulation. There was no difference in 4.560.7 nM (P,0.05, n58). Noradrenaline did not atheart rate and mean arterial blood pressure between the tenuate the dialysate ACh response in the presence of first and the second vagal nerve stimulations.
v-conotoxin GVIA (from 3.861.4 to 3.561.3 nM, n57). 
Protocol 4: influence of stimulation frequency on n56)
, from 9.561.8 to 5.461.2 nM at 10 Hz (data from noradrenaline-induced inhibition (Fig. 4) protocol 1), and from 12.162.6 to 10.662.2 nM at 20 Hz (P,0.05, n56). The inhibitory effect of noradrenaline on Noradrenaline significantly attenuated the dialysate ACh dialysate ACh response was 45610% at 5 Hz. This value response from 3.560.4 to 2.060.5 nM at 5 Hz (P,0.05, was almost same as 4465% at 10 Hz (data from protocol 1). But the inhibitory effect at 20 Hz (1263%) was ergic receptors. This inhibition is likely to be mediated by significantly smaller than those at 5 Hz or 10 Hz (P, a-adrenergic receptors. 0.05).
Extracellular washout as well as hydrolysis is considered to be a significant factor for the inactivation of released ACh in the heart [18] . Systemic administration of norad-4. Discussion renaline could cause hemodynamic changes and alter myocardial blood flow. These alterations might influence Using dialysis technique, we investigated the influence the dialysate ACh response. In our study, noradrenaline of local administration of noradrenaline on endogenous was locally administered through the dialysis probe and ACh release induced by electrical stimulation of vagal heart rate was maintained by ventricular pacing during nerves in the in vivo heart. Noradrenaline inhibited endogvagal nerve stimulation. Mean arterial blood pressure and enous ACh release induced by electrical stimulation of myocardial blood flow around the dialysis fiber did not vagal nerves and this inhibition was blocked by phenchange. Thus, the influence of noradrenaline on washout tolamine.
factor would be negligible when considering factors influencing dialysate ACh response in our experiment. 4.1. Adrenergic inhibition of ACh release 21 
Involvement of N-type Ca channel in adrenergic
The experiments of perfused isolated atria have been inhibition of ACh release extensively used for the investigation of ACh release from 21 21 the heart. In the isolated rat atria, noradrenaline inhibited Ca influx through the voltage-dependent Ca chan-1 the high K -induced release of radiolabeled ACh and this nels is the trigger for the neurotransmitter release from inhibitory effect was blocked by a -adrenergic antagonists nerve terminals. It has been reported that neurons have a 1 21 [7]. Similarly, in the isolated guinea pig atria, noradnumber of different types of voltage-dependent Ca renaline inhibited the field stimulation-induced release of channel [19] . In the isolated guinea pig myenteric ganglia, radiolabeled ACh, and a -adrenergic antagonists prevented ACh release evoked by nicotinic agonist was inhibited by 2 this inhibitory effect of noradrenaline [8] . These studies v-conotoxin GVIA [20] . Similarly, in the perfused guinea have suggested that ACh release from cardiac vagal nerves pig trachea, v-conotoxin GVIA inhibited ACh release is regulated through presynaptic a-adrenergic receptors.
from airway vagal nerves induced by electrical field 21 On the other hand, in the isolated chicken heart, adrenergic stimulation [21] . These studies suggest that Ca influx 21 agonists did not alter ACh release by vagal nerve stimulathrough N-type Ca channels is primarily involved in tion [16] . Similarly, in the isolated guinea pig atria, ACh release. Also in our experiment, v-conotoxin GVIA noradrenaline was not able to modulate the field significantly attenuated the dialysate ACh response, but 21 stimulation-induced release of radiolabeled ACh [17] . nifedipine did not. We consider that Ca influx through 21 These different results might be due to species differ-N-type voltage-dependent Ca channels predominantly ences or methodological differences. The preparation of triggers ACh release from postganglionic cardiac vagal perfused isolated atria includes preganglionic and postnerve terminals. ganglionic vagal nerve terminals, and vagal ganglion cells Previously, we demonstrated with the same preparation [18] . Therefore, adrenergic agonists could act on all nerves that v-conotoxin GVIA completely blocked the 1 and high K or field electrical stimulation could release stimulation-induced noradrenaline release [22] . Compared ACh from both the preganglionic and postganglionic vagal with this inhibitory effect of v-conotoxin GVIA on nerve terminals. The different results might partly attribute noradrenaline release, that on ACh release (5364%) was to this vagal anatomical complexity.
smaller. Not only N-type but also other types of voltage- 21 Previously, we demonstrated that local administration of dependent Ca channels resistant to v-conotoxin GVIA the nicotinic antagonist hexamethonium did not influence might be partly involved in ACh release from postganthe dialysate ACh response to vagal nerve stimulation, and glionic cardiac vagal nerve terminals. that intravenous administration of hexamethonium comPresynaptic receptors can regulate voltage-dependent 21 1 pletely blocked this dialysate ACh response [10] . We Ca channels and K channels on the nerve terminals, 21 concluded that the vast majority of dialysate ACh is resulting in changes in Ca influx and in neurotransmitter derived from postganglionic vagal nerve terminals, and release [13, 14] . In isolated frog sympathetic ganglia, athat preganglionic vagal nerve terminals and vagal gangadrenergic inhibition of noradrenaline release was me- 21 lion cells scarcely exist around dialysis fiber. Thus, we diated by reducing the activity of N-type Ca channel considered that all pharmacological agents acted predomigating [23] . In an identified cholinergic synapse, it has 21 nantly on the postganglionic vagal nerve terminals in the been suggested that Ca influxes through N-and P-type 21 21 present study. These considerations lead us to believe that Ca channels trigger ACh release, but only N-type Ca noradrenaline inhibits ACh release from postganglionic channels are influenced by presynaptic receptors [24] . In cardiac vagal nerve terminals through presynaptic adrenour study, noradrenaline did not attenuate the dialysate ACh response to vagal nerve stimulation (10 Hz) in the vagal nerve terminals in the heart, we need to perform the presence of v-conotoxin GVIA (Fig. 3) . Almost the same simultaneous stimulations of cardiac sympathetic and vagal dialysate ACh response was elicited by vagal nerve nerves at various stimulation frequencies. Furthermore, in stimulation at 5 Hz, but noradrenaline significantly atquantitative comparison with earlier in vitro studies, we tenuated this ACh response (Fig. 4) . These different need to conduct detailed dose-response curve to define the responses suggest that presynaptic adrenergic inhibition of receptor subtype. 21 21 Ca influx through N-type Ca channels could play a predominant role in the decrease in ACh release.
